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ivExecutive summary
This report documents a service evaluation of 
Population Services Zimbabwe (PSZ) mobile outreach 
programme in four provinces of Zimbabwe. The 
evaluation was conducted by the Population Council 
between September and October 2013. This study was 
made possible through the United States Agency for 
International Development (USAID) funded Support for 
International Family Planning Organizations - Marie 
Stopes International (SIFPO-MSI) project. It provides 
key findings on the quality of the PSZ outreach 
programme in expanding choice and access to 
long-acting reversible contraceptives (LARCs) and 
permanent methods (PMs) of contraception, as well as 
recommendations for PSZ and other family planning 
programmes to consider in scaling up and 
strengthening mobile outreach services. The 
evaluation, conducted by Population Council, was 
designed to focus on various components of quality 
including adequate information and counselling on 
methods and services, good clinical procedure with 
minimal occurrence of adverse events, client health-
seeking behaviour and client satisfaction. The level of 
integration of HIV and other SRH-related services into 
the family planning programme was also evaluated. 
The fertility rate in Zimbabwe is 4.1 children per woman 
and the contraceptive prevalence rate (CPR) is 59% 
[1]. The most recent Zimbabwe Demographic and 
Health Survey (ZDHS) 2010-2011 reported that if all 
married women with an unmet need for family planning 
were to use contraception, the CPR would increase 
from 59% to 74% [1]. Government-sponsored facilities 
in Zimbabwe remain the main providers of 
contraceptive methods, where 73% of all women who 
use modern contraceptive methods obtain them from 
the public sector. Integration of other services into 
sexual and reproductive health services, including HIV, 
has been outlined in the National Strategic Plan and 
other health policies through support of the Ministry of 
Health and Child Care (MOHCC). As a result, family 
planning services and clinics are now to provide HIV 
testing and counselling and other reproductive health 
services according to the 2011-2015 ZNASP [2]. 
Marie Stopes International (MSI) uses a mobile 
outreach model to increase the availability and choice 
of family planning services, with a particular focus on 
expanding access to LARCs/PMs among men and 
women living in rural and hard to reach areas. PSZ, a 
member of MSI Global Partnership, is one of 
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Zimbabwe’s largest specialised SRH organisations, 
known for providing a wide range of high quality, 
affordable and client-oriented services. PSZ currently 
provides mobile outreach services through eight teams 
covering over 500 sites throughout the country. The 
mobile teams (consisting of four to five staff) 
complement the government’s facility level services 
with a focus on areas where family planning is not 
otherwise available. The service includes providing 
short-term family planning services (pills, condoms, 
emergency contraception, and injectables), LARCs 
(implants, IUDs) and PMs (tubal ligation and 
vasectomy). 
While expanding the availability of family planning 
methods is important, it is equally important that the 
quality of these services are maintained to ensure that 
family planning procedures are safe and meet the 
expectations of clients. Under the auspices of the 
USAID-funded SIFPO-MSI project, Population Council 
carried out an evaluation of PSZ’s mobile outreach 
services in four provinces in order to inform and 
improve PSZ’s family planning service provision. 
Between September and October 2013, 665 women 
receiving a tubal ligation, implant or IUD were recruited 
from high volume sites for the study. Data collection 
included observing client-provider interaction and 
service provision as well as interviewing clients 
immediately following the service on the day of the 
procedure. Clients were then asked to return 15 days 
post procedure, at which point they were interviewed 
about adverse events and health seeking behaviour.   
The median age of clients was 26 years and 43% had 
a child less than a year old. All except one client (664) 
reported having living children of which 22% (n=145) 
reported having one living child and 31% (n=207) had 
two living children. 23% (n=153) reported having three 
living children and 11% (n=74) reported having four 
living children. 40% of clients reported that they 
planned to have a child “more than five years from 
now”. Most women in the study had achieved primary 
or secondary education, with clients from rural areas 
achieving a lower educational status (primary) 
compared to those from urban areas. 39% (n=260) of 
clients reported having discussed seeking family 
planning services with their partner/spouse. 
Information on HIV testing and sexual risk behaviour 
was collected during the client exit interview. 95% of 
vclients reported that they had been tested for HIV at 
some point in the past. 19% of clients reported having 
more than one partner in the past 12 months. Condom 
use was low as only half of the women (49%, n=272) 
reported “ever” having used a condom (male or 
female) of which only 29% (n=79) reported “always” 
using a condom and 24% reported that they had 
unprotected sex in the last three months. This 
indicates that clients may be at significant risk of HIV 
and would likely benefit from HIV-related information 
and services. 
Data from the client exit interviews showed that 91% of 
clients chose an implant as their preferred method of 
contraception, 7% chose an IUD and 1% chose tubal 
ligation. Client satisfaction was high, with 100% 
reporting that they would use the PSZ family planning 
services again. However, only 68% reported that they 
would refer the family planning service to a friend; 57% 
reported that they would refer a family member; and 
21% reported they would tell a stranger about the 
service. 
To assess quality of care including information provided 
and level of integration of HIV/SRH services, research 
nurses observed client-provider interactions. 
Specifically, to measure integration of services, it was 
observed whether clients received HIV and AIDS 
counselling, counselling on dual protection, pregnancy 
testing, gender-based violence and STI services 
(information, testing & treatment). The presence of 
obstetrics and breast cancer history screening was also 
assessed. For all the clients (100%), it was observed 
that they were provided with information on the risks 
and benefits of the chosen method of contraception as 
well as the risks and benefits of using male or female 
condoms as a single or dual method of protection 
against HIV. 61% of clients were provided with HIV and 
AIDS counselling. 58% of clients were observed being 
asked about STIs. 94% of clients were asked about 
their obstetric history and 62% of clients were provided 
information on gynecological issues including obstetrics 
and breast cancer. In only 12% of observations gender 
based violence (GBV) issues were discussed. In client 
exit interviews, 95% of clients reported that they were 
told by the providers on how to manage side effects 
they may experience after receiving their choice of 
family planning method. 
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As indicated from client exit interviews, a significant 
proportion of clients had misconceptions regarding the 
various contraceptive methods that persisted after the 
group education and counselling. Some commonly 
reported beliefs included: women who have never had 
a baby cannot use an IUD or DMPA and IUDs cause 
discomfort to the partner during sex. Some clients felt 
that hormonal contraceptives could cause cancer and 
as many as 29% of clients said pills can make a 
woman sterile. 
During the Day 15 follow-up visits, 91% of clients 
(N=555) returned, all of whom were asked if they had 
experienced a side effect1 and if so, whether they had 
sought care when they had experienced the side 
effect. 386 clients reported experiencing symptoms at 
some point (i.e. on day of procedure up to and 
including Day 15 follow up). Most clients reported 
experiencing expected side effects on the day of the 
procedure. 32% (n=180) of clients indicated that they 
experienced a side effect up to Day 15. 96% of clients 
did not experience a side effect requiring follow up 
treatment.
Of the 4% (n=24) who did experience a side effect 
requiring follow up one half called the PSZ helpline to 
enquire about the side effect/s they had experienced. 
Of those who called the helpline, half returned to the 
facility and were seen by a facility provider prior to the 
Day 15 follow up visit. One percent of all women (n=8) 
experienced a constant temperature and fever and 
had to visit the health facility to have the method 
removed. These eight clients reported no longer 
experiencing these side effects on the 15 day follow 
up visit. Five of these eight clients reported being 
satisfied with the follow up treatment they received 
from the facility provider. One client, an IUD acceptor, 
reported that the PSZ provider had observed a 
moderate hematoma or bruising. This required wound 
revision and the release of a build-up of blood and the 
treatment and care was provided by the nurse from 
the PSZ team at the Day 15 follow up. 
The study demonstrated that the quality of service and 
client satisfaction is high amongst all those that 
received family planning services from PSZ mobile 
outreach sites. Clients were able to articulate the 
management of side effects during the client exit 
interview on Day 1. The data reveals that there is 
1  Side effects are defined as symptoms that are a result of the procedure or drug that is generally not a sign of a health problem, nor related to the skill 
of the provider, and requires resting or no medical intervention or treatment. The client may be aware of the problem all the time but still able to do 
normal daily activities
vi
some level of HIV and SRH integration into the PSZ 
model of family planning, however not all clients are 
being offered all services. Most clients that 
experienced side effects were aware of how and 
where to seek health services prior to their Day 15 
follow up visit. Although a high number of adverse 
events were reported, the majority were categorised 
as either “very mild” or “mild” and constituted expected 
side effects of the family planning method or 
procedure. There were no serious complications 
reported.
Recommendations for PSZ:
•  Stronger integration of SRH services such as HIV 
and STI counselling and testing could provide an 
opportunity to intensify HIV prevention activities 
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amongst family planning clients such as HIV 
re-testing and condom use. 
•  Only 39% (n=260) reported having discussed 
family planning with their spouse or partner. 
Therefore a recommendation may be to include 
spouses or partners in family planning campaigns 
to involve them in the family planning services 
women receive with the aim to strengthen HIV and 
SRH integration.
•  A significant proportion of clients continue to have 
misconceptions and incorrect information about the 
various contraceptive methods. PSZ health care 
providers should continue to focus on correcting 
myths and misconceptions routinely in group or 
individual counselling as part of their family 
planning community outreach activities. 
vii
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Zimbabwe has a population of 13 million [1]. 41% of the 
population is below the age of 15 years, 55% are 
between 15 and 64 years and 4% are 65 years or older 
[1]. The adolescent population is estimated to be 
1,656,000 and the number of women of reproductive 
age (15-49 years) is approximately 3,246,000 [3]. The 
total fertility rate is 4.1 children per woman. For women 
in Zimbabwe, childbearing during ages 20-24 years and 
25-29 years is at its peak and then drops sharply after 
the age of 39 years. Fertility among urban women is 
markedly lower (3.1 children per woman) as compared 
to rural women (4.8 children per woman). Zimbabwe’s 
CPR is 59% and the proportion of women with an unmet 
family planning need is 13% [1]. The Demographic 
Health Surveys define unmet need for family planning 
as “all fecund women who are married or living in union, 
and thus presumed to be sexually active, who either do 
not want any more children or who wish to postpone the 
birth of their next child for at least two more years but 
are not using any method of contraception” [1], [3]. 
Approximately 211,000 women want to delay or avoid 
falling pregnant but do not have access to modern 
methods of contraception [4]. Fertility has fallen among 
women over the age of 20 years in the past two 
decades, although there has been a noticeable increase 
among those between 15 and 19 years [6]. Trends 
reveal that fertility declined between 1988 and 2005/6, 
from 5.4 children to 3.8 children per woman, but 
increased in 2010/11 to 4.1 children per woman [1]. The 
Zimbabwe Demographic and Health Survey (ZDHS) 
2010-2011 reported that contraception use in Zimbabwe 
has remained unchanged since 2005/6, and that if all 
married women with an unmet need for family planning 
were to use a contraceptive method, the CPR would 
increase from 59% to 74%. 
Education levels are closely linked to a woman’s fertility: 
women with no formal education and women with a 
primary education have between five and six children, 
respectively, while women with at least some secondary 
education have approximately four children or less [1]. In 
addition, women and/or their partners in poor socio-
economic circumstances are less likely to use 
contraception [7], specifically if the women are over 35 
years old, less educated, own less household items, 
and live in rural areas [8]. In Zimbabwe, 98% of women 
and 99% of men know about at least one contraception 
method [1]. Most of the women in rural areas depend on 
mobile clinics and community based distribution for their 
contraceptive supplies, while those in urban areas get 
their supplies from clinics and pharmacies [9]. 
Government-sponsored facilities remain the main 
providers of contraception with 73% of women who use 
modern contraceptive methods obtaining them from the 
public sector [1]. Table 1 overleaf provides with an 
overview of family planning in Zimbabwe and four of its 
provinces i.e. Harare, Masvingo, Matebeland South and 
Matebeland North.
Zimbabwe has monitored the HIV epidemic to assess 
HIV prevalence in pregnant women attending antenatal 
care (ANC) services. The country has a generalised 
heterosexually driven HIV epidemic with a prevalence of 
14% [1]. 95% of women attended ANC at least once 
during their most recent pregnancy [5] and an estimated 
1,159,097 adults and children were living with HIV and 
AIDS in 2011 [10]. While family planning programmes 
have led to an increase in the percentage of women 
using contraceptives and improvements have been in 
the use of LARCs/PMs that are preferred by clients, 
these offer no protection against HIV [11].
In Zimbabwe, women from all backgrounds are subject 
to violence, where 27% of women reported that they 
have experienced sexual violence at some point in their 
lives and only 37% of women who have ever 
experienced any physical or sexual violence have 
sought help from any source [1]. Addressing gender 
dynamics and the related issue of gender based 
violence as part of integrated SRH services within 
family planning [12], has been included in Ministry of 
Health and Child Welfare (MoHCW) policies [13], as 
experiencing violence increases a woman’s’ risk to HIV 
and reduces contraceptive use [14].
2.1 Population Services Zimbabwe
PSZ, a member of Marie Stopes International, is one of 
Zimbabwe’s largest specialised SRH organsations, PSZ 
currently provides mobile outreach services in nine of 
Zimbabwe’s ten provinces through eight teams visiting 
over 500 sites at different times. The districts are 
covered through a network of eight static clinics and 
eight mobile outreach teams and take place in MoHCW 
clinics, schools, private facilities, outdoors with 
temporary structures etc. Expansion of these sites is 
currently underway. PSZ aims to increase access to 
family planning services for women, men and 
adolescents in rural and hard-to-reach communities. 
Mobile outreach services make use of an integrated 
2. Introduction 
Introduction 
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TABLE 1: Family Planning data for Harare, Masvingo, Matabeland South, Matabeland North and Zimbabwe 
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Total fertility rate per woman 4.1  3.1 4.7 4.2 4.1
Contraceptive prevalence rate (%) 59 59 54 46 51
(CPR) for modern methods 57 58.2 54.0 45.2 49.3
Female sterilisation 0.9 1.1 1.2 1.2 0.7
IUD 0.2 0.3 0 0.2 0.8
Male sterilisation 0
Pill 27.3 45.8 4.4 19.8 27.6
Injection 6.1 3.5 7.6 15.7 12.2
Male Condom 3.5 3.2 1.7 4.3 1.6
Female Condom 0.3 0.4 0.2 0 0
Traditional methods (withdrawal, periodic 
abstinence)
0.8 1.2 0.2 1.0 1.4
Total unmet need for family planning 12.8 12.6 11.7 26.2 13.2
Unmet need for spacing births 5.5 7.1 9.0 13.7 6.2
Unmet need for limiting births 7.3 5.5 2.7 12.5 7.0
Maternal mortality ratio (MMR) 960 per 
100,000 
live births 
Introduction 
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approach that combines community based information 
education and communication (IEC) and service 
provision. PSZ provides the full method mix of family 
planning services (eg. condoms, pills, injectables, 
implants, IUDs and PMs) through its outreach mobile 
sites. PSZ has also embraced the global call for 
repositioning family planning through integration of STI 
and HIV services. Currently PSZ employs the 
syndromic approach per national guidelines to screen 
and treat for STIs. Mobile service delivery involves 
having contraceptives provided by a team of trained 
providers, either through periodic visits to a lower-level 
facility or from a mobile unit itself in an area with limited 
or no family planning services. Typically, a PSZ 
outreach mobile clinic consists of a team of four and a 
vehicle equipped to provide contraceptive services, 
including LARCs/PMs, which often complement the 
readily available short term methods and broaden 
available methods and choices for women. Depending 
on the location and methods provided, teams are 
usually staffed by nurse aide, clinical officers, or 
physicians, and a driver. 
PSZ implements a quarterly internal quality technical 
assistance (QTA) and an annual external QTA that 
assesses infrastructure, supplies, procedure 
correctness and inputs for an effective programme. 
However, this does not include independent verification 
of aspects of quality of counselling and information. 
Additionally, the understanding of information on 
relevant services, HIV integration, referrals, and 
information on client and provider behaviour in the event 
of a side effect experienced by the client, has not been 
systematically documented. As part of their mobile 
outreach quality assurance programme, MSI undertook 
to evaluate the mobile outreach services in Zimbabwe, 
which are delivered at primary health care (PHC) 
facilities. Although this evaluation focused on services 
provided by PSZ outreach teams, it aims to contribute to 
the national knowledge base, especially in communities 
where PSZ conducts and will conduct future mobile 
outreach services. The evaluation will inform the 
national family planning programme, as well as the 
overall quality of services provided by PSZ nationally. In 
2012, PSZ, added 268,919 couple years of protection 
for clients accessing family planning services [15]. The 
results from this evaluation are expected to guide PSZ 
on how to further strengthen their mobile outreach 
services and develop new strategies to enhance service 
delivery standards. Table 2 documents the processes 
PSZ undertakes for mobile outreach services.
Pre-procedure steps:
1.  Comprehensive group family planning counselling: information is provided on all family planning methods, including 
benefits and drawbacks, myths and misconceptions by a PSZ staff member.  
2.  Client registration. 
3.  One-to-one counselling: Clients are individually counselled using a client-centred approach, more detailed information is 
provided regarding the method chosen by the client (including side effects) by a PSZ health care provider.
4.  History taking and medical check-up/screening.
5.  Voluntary and Informed consent obtained (given in writing by the client for permanent methods per MoHCW standards).
6.  Medical tests as required, including urine and blood tests.
7.  Anaesthesia provision (when indicated by method).
Post procedure follow-up care: 
All clients at PSZ outreach sites complete registration and the recording of PSZ services are documented in the registers. All 
clients are counselled post procedure on how to deal with side effects and instructions for after care. They are also given the 
contact telephone number of the PSZ Helpline and PSZ Team Leader in case they were in need of contacting a PSZ provider. 
Tubal ligation clients Provided with pain relief, anti-inflammatory medication, tablets. 
IUD clients All IUD clients are counselled to return to the facility at six weeks post procedure and are 
attended by MoHCW nurses. Three month and one-year follow ups occur when PSZ returns to 
the outreach site. 
Provided with pain relief medication. 
TABLE 2: PSZ clinical standards for mobile outreach
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•  Sub-objectives
– Assess the quality and levels of satisfaction with 
regard to counselling and information provided.
– Assess information provided to clients on what 
steps to take if they experienced a side effect.
– Assess the level of integration of HIV services 
into contraceptive or other SRH services. 
Objective 2: Measure the occurrence of side effects 
associated with LARCs/PMs up to 15 days post-
procedure with an emphasis on understanding health 
seeking behaviour for side effects.
•  Sub-objectives
– Measure the timing, frequency and type of side 
effects occurring between 0 to 15 days.
– Assess women’s health-seeking behaviours 
when experiencing a side effect.
– Determine access to follow-up care for women 
with a side effect.
2.2 Study aims and objectives
This study was commissioned to complement PSZ’s 
regular quality assurance procedures for outreach 
services in Zimbabwe. The external evaluation, 
conducted by Population Council, was designed to 
focus on various components of quality including 
adequate information and counselling on methods and 
services, good clinical procedure with minimal 
occurrence of adverse events and client satisfaction 
with the services provided by outreach clinics. 
Additionally, health seeking behaviour of clients was 
evaluated in the event that side effects were 
experienced. The findings of the study are intended to 
be used by PSZ to improve quality of outreach services. 
Quality was measured through data collection of direct 
observation of client counselling and service provision, 
client exit interviews on the day of service and at a 15 
day follow-up visit.   
Objective 1: To evaluate the quality of services (service 
provision and counselling) provided to clients attending 
mobile outreach services for a range of family planning 
methods provided by the PSZ mobile health teams. 
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3.1  Study design, location and 
participants 
This evaluation involved recruiting a convenience 
sample of 665 women receiving family planning 
services from PSZ mobile outreach sites between 
September and October 2013. Of all the provinces 
PSZ is working in, the four provinces with highest 
coverage, Harare, Masvingo, Matebeleland North and 
Matebeleland South  were selected on account of 
having sites in which a high number of clients 
accessed family planning services during the period 
January to July 2013. Additionally, these provinces 
provided a representation of urban, peri-urban and 
rural areas. 
Women were eligible to participate in the study if they 
had received a family planning service, signed an 
informed consent and indicated that they were willing 
to return for the 15 day follow up visit. 
Sampling
The sample size was guided by logistic considerations 
and the need to ensure that the study evaluated the 
quality of care provided by all eight PSZ mobile teams. 
A sample size of 665 clients was achieved during the 
data collection period, which represents an average of 
83 women per mobile team.    
Survey instrument, data collection and data 
analysis 
Each PSZ outreach team had an accompanying 
research team of five people in total consisting of three 
female data collectors, one nurse and one team leader 
who carried out recruitment, conducted client exit 
interviews and 15 day follow-up interviews. Clients 
were recruited for the study prior to their procedure at 
the outreach site, and following informed consent, 
were observed whilst receiving counselling and family 
planning service provision. During the client-provider 
observation, the nurse explained her presence to the 
clients and provided assurance that the privacy and 
confidentiality of all study participants would be 
maintained throughout the process. 
3. Methodology
During the procedure, the research nurse completed 
the client-provider observation tool which included 
questions on how the provider greeted and assessed 
the client, family planning method selection and client 
counselling and observation of specific processes. 
Following the procedure, clients were interviewed 
about their background characteristics; knowledge and 
source of information about the outreach services; 
previous use of contraception, satisfaction of the 
service they had just received, experience of 
immediate adverse event and reasons for opting to 
receive the service from PSZ. Clients receiving tubal 
ligation were given adequate time for recovery (a 
minimum of 45 minutes) post-procedure prior to 
conducting the exit interview. All clients were asked to 
return to the clinic 15 days post-procedure and 
received a follow-up card. The cost of travel for this 
interview was covered by the study. At the Day 15 
follow up interview, the interviewer collected 
information on side effects, health care seeking 
behaviour, resumption of normal activities and 
satisfaction. If clients did not return to the site for a 
follow up interview, attempts were made to contact 
respondents by telephone only if the client had agreed 
to be contacted during informed consent. At the Day 
15 follow up visit, all clients that returned were asked 
to consent again.  
Data collection was conducted between 9th and 17th 
September 2013. All data related to adverse events 
(side effects or complications) on the day of the 
procedure, at post-procedure or those that “still 
existed” at the Day 15 follow up visit were collected 
through client interviews. Table 3 provides a 
description of adverse events that the clients were 
asked to self-report on which was related to their 
choice of family planning method.
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TABLE 3: Summary description of adverse events that clients were asked to report
2  Adapted from a similar MSI outreach evaluation: Reiss K, Nantayi L, Odong J & Ngo TD. Providing long acting and permanent contraceptives through 
outreach in rural Uganda. MSI, 2012
Type of adverse event Description
Very mild The client experiences low level of discomfort that does not require any medical 
intervention
Mild The client experiences some level of discomfort that only requires resting or minimum 
level of medical intervention such as taking pain relief from a medical shop
Moderate The client experiences more frequent level of discomfort that requires attention from 
medical personnel, such as a doctor
Severe The client experiences frequent level of discomfort that requires either further medical 
check-up or hospitalisation
TABLE 4: Categories of adverse events2
Type of family 
planning
Implant IUD Tubal Ligation
D
es
cr
ip
tio
n 
of
 S
ym
pt
om
s
Pain at insertion site
Bleeding at insertion site
Menstrual cycle (change in 
bleeding)
Scarring
Change in breast since 
implants (eg. tenderness or 
lumps)
Change in blood pressure
Infection (eg. Fever, pain, 
redness or discharge at 
insertion site)
Expulsion of implants
Pain at time of insertion
Pain (related to cramping post-
insertion)
Vaginal bleeding
Infection (eg. Fever, abdominal 
pain, discharge)
Expulsion of IUD
Pain at time of 
insertion
Pain (related to 
cramping post-
insertion)
Vaginal bleeding
Infection (eg. Fever, 
abdominal pain, 
discharge)
Expulsion of IUD
Data collection was conducted between 9th and 17th September 2013. All data related to adverse events (side 
effects or complications) on the day of the procedure, at post-procedure or those that “still existed” at the 15 day 
follow up visit were collected through client interviews. Table 3 provides a description of adverse events that the 
clients were asked to self-report on which was related to their choice of family planning method.
The study design, development of survey tools and data collection was managed by the Population Council. Data 
was entered on data collection templates developed in Epi Info 7. Descriptive statistical methods were conducted 
using the Statistical Package (STATA Version 12).
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4. Findings
4.1 Study recruitment 
The sample was recruited from four provinces: 
Harare, Masvingo, Matabeland South and Matabeland 
North. The evaluation was conducted at 26 mobile 
outreach sites in eight districts. The majority of 
services were delivered in rural locations (77%) with 
the remaining delivered in urban and peri-urban areas 
(24% and 7% respectively). The facility level 
distribution of implant, IUD and tubal ligation clients 
recruited for the study is provided in Table 5.
TABLE 5: Respondents recruited by outreach mobile sites, district province and outreach teams. Distribution of 
tubal ligation, IUD and implant clients recruited for the study by district
Mobile Outreach 
Teams by Province
District Mobile Team Sites Number of 
Respondents
1. Masvingo Outreach 
Teams
Chiredzi Chinzvinzvi 18
Chiredzi Poly 44
Ndali 29
Rupangwana 24
St Joseph 30
Feversham 27
2. Harare Outreach 
teams
UMP Mashambanhaka 24
Nyanzou 8
Chipfunde 11
Manyika 16
Nhakiwa 28
Seke Beatrice 20
Mutoko Mushimbo 24
Ruwa Ruwa 95
3. Nkulumane Outreach 
teams
Umguza Insiza 37
St James 10
Hope Fountain 25
Durban and Queens Mine 12
Kensington 29
Lupane  St Lukes 46
4. Bulawayo Outreach 
Teams
Umzingwane Mzingwani 12
Sibomvu 40
Mawabeni 23
Mbizingwe 10
Habane 23
TOTAL 665
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FIGURE 1: Study cohort profile
702 women registered for outreach services
665 eligible clients to participate
Loss to follow 
up: 55
7 tubal 
ligation
Not eligible: 37
100%  
tubal ligation 
91% 
 Implants
Day 1
Day 15
Findings
During the study period 702 clients were recruited to 
participate in the study and out of these women, 665 
were eligible to participate in the study. Those who 
were not eligible could not be provided with 
contraception due to medical reasons identified during 
the consultation or had decided not to receive a family 
planning method. Table 6 shows the distribution of the 
sample for the clients recruited in each of the outreach 
facilities. In total, 1% (n=7) of clients received a tubal 
ligation, 7% (n= 48) of clients accepted IUDs and 92% 
(n=610) of clients opted for implants. At the 15 day 
follow up visit, 91% (n=555) of the required sample 
size returned to the facility. While all of the tubal 
ligation and IUD clients returned, 91% of implant 
clients returned. 55 clients were loss to follow up (see 
Figure 1). 
610  
Implants
48  
IUD
100% 
 IUD
4.2 Socio demographic characteristics
The median age of clients was 26 years. Eight clients 
were aged between 14 and 16 years old which are 
included in the 15-19 year old group in the table below. 
Almost three quarters (74%) of women were married 
and almost all had more than one child (99%) (see 
Table 7). The number of living children clients had was 
fairly evenly distributed. The majority of clients had two 
children (31%), while the remaining were evenly split 
between those having one child, three children or four 
or more children.  
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TABLE 6: Client socio-demographic characteristics
Socio-demographic characteristics  (N=665) % (n)
Age of women      (years)                        [mean] 26 years
Under 20 (15-19) 12% (n=77)
20-24 31% (n=206)
25-29 24% (n=157)
30- 34 17% (n=110)
35+ 17% (n=114)
Number of living children [mean] 3
0 0% (0)
1 22% (n=145)
2 31% (n=207)
3 23%(n=153)
4 or more 23% (n=145)
Education
Primary 39% (n=252)
Secondary 59% (n=384)
Graduate 1% (n=4)
Technical education 1% (n=9)
Professional education 1% (n=4)
Other 0%(n=1)
Occupation
Housewife 49% (n=324)
Petty business 8% (n=55)
Business including retail shop 1% (n=5)
Farmer 14% (n=94)
Agricultural labourer 7% (n=48)
Teacher 1% (n=4)
Factory / Production worker 0% (n=2)
Managerial / Professional 4% (n=23)
Office attendant 0% (n=2)
Student 1% (n=5)
Other 16% (n=103)
Average monthly household income USD 177. 88
% of clients living under $1.25/day 6% (n=33)
% of clients living under $2.50/day 7% (n=36)
Client risk Profile
Disclosing family planning to partner 39% (n= 260)
Partner supportive of receiving family planning service 39% (n= 260)
Clients reported ever receiving an HIV test 95% (n=632)
HIV test in last 12 months 12% (n= 78)
last HIV test > 18 months ago 58% (n=383)
Self-reported sexual behaviour
One partner 81% (n=481)
Two partners in last 12 months 9% (n=49)
More than two partners in last 12 months 1% (n=5)
Unprotected sex in last 3 months 24% (n= 406)
“ever” used condom 49% (n=272)
“always” used condom 29% (n=79)
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4.3 Previous contraceptive use
To measure the degree to which outreach services 
expand access and choice, particularly for LARCs/
PMs, clients were asked about prior contraceptive use. 
All of the women in the study reported having used a 
contraceptive method at some point prior to receiving 
the PSZ service. The majority of clients reported use 
of short-acting methods including the pill (n=328), 
injectable (n=94) and male condoms (n=65).  A 
minority of clients reported that they were using a 
long-acting method including IUD (n=5) and implant 
(n=54). Clients were also asked whether they had 
become pregnant whilst using a method of 
contraception in the past. 62% of women reported that 
they were using some form of contraception when they 
became pregnant. The contraceptive pill was cited 
most frequently as the failed method. Most of these 
women (85%) reported switching to a LARC/PM after 
the unplanned pregnancy.  
4.4 Quality of care
Quality of counselling and information 
To evaluate quality of care, the provider-client 
interaction was observed to assess data collection on 
whether a client-focused approach was used, the 
quality of counselling and information, screening and 
eligibility and post-procedure counselling.  The client 
provider observation tool was used by the research 
nurses during observation. Observation was 
conducted with all clients irrespective of the family 
planning method chosen and the interaction between 
the service provider and client during the procedure. 
Confidentiality and privacy during the procedure was 
also noted.
The client-focused approach specifically assessed 
whether the provider: used the client’s name during the 
consultation; used a kind and inviting voice; listened to 
the client; encouraged the client to ask questions and 
assisted the client in making a decision when choosing 
an family planning method. Assisting clients in 
decision-making involves providers giving non-
judgmental and non-directive support to ensure clients 
make an informed choice and feel comfortable with 
their SRH decisions. Client-provider observation data 
indicates a generally high level of client-focused 
approach in which 95% of interactions included using a 
kind and inviting voice and listening to the client, and 
83% encouraging clients to ask questions (see Figure 
2).
Client-provider observations were supported with 
findings from the client exit interviews which included 
FIGURE 2: Elements of the client focused approach
Use client’s name
Kind & inviting voice
Listen to the client
Encourage client to ask questions
Assist client in decision making
Findings
0%  20%  40%  60%  80%  100%
69%
95%
95%
83%
53%
Data Source: Client Provider Observation
11Findings
questions on client-centered approaches. Figure 3 
shows the client reported data such as greetings and 
mannerisms the provider displayed. 
Quality of counselling and information provided by 
providers was also found to be high. For all the clients 
(100%), it was observed that they were provided with 
information on the risks and benefits of the chosen 
method of contraception as well as the risks and 
benefits of using male or female condoms as a single 
or dual method of protection against HIV. 94% of 
interactions included provision of accurate information. 
From the client exit interviews, 93% of clients reported 
that they were provided with adequate information on 
the different types of contraception available through 
the PSZ mobile outreach services, 92% felt they were 
FIGURE 3: Quality of care for family planning services
Friendly / respectful manner
Used kind & inviting voice
Provider listened
Provider used client record
Seen in a private  area
Received counselling base on family 
planning choice
Provided with accurate information
Provided with date of return visit
0%  20%  40%  60%  80%  100%
97%
97%
97%
97%
99%
93%
94%
87%
Data Source: Client exit interview
aware of the risks and benefits of the different 
contraception methods, side effects for each of the 
contraceptive methods provided by PSZ and what to 
do should they experience a side effect (95%). This 
data was collected during the client exit interview after 
the client had received both group and individual 
counselling as well as the family planning method of 
their choice.
Client history 
Most providers captured the required elements of the 
clients’ medical history during the visit. It was observed 
that 94% of clients were asked about their obstetrics 
history followed by hypertension (83%). Fewer than 
half of clients (43%) were asked if they experienced 
migraines or headaches by the provider. Only 36% of 
12
clients were asked whether or not they smoked. Figure 
4 and Table 8 provide details on specific screening 
topics and history taking from client provider 
observations.  
Client satisfaction 
At enrolment all clients (100%) stated that they were 
happy and satisfied with the family planning service, 
however only 21% of clients indicated that they would 
“recommend the service” to a stranger, 57% to a family 
member and 68% to a friend. 
Client satisfaction was also recorded at the 15 day 
follow up visit among the clients that returned. When 
asked whether they would “recommend the family 
planning method” to other women all tubal ligation 
clients (n=7), 88% (n=38) of IUD clients and 89% (n= 
471) of implant clients reported that they would 
recommend their family planning method to other 
women. However, one tubal ligation client, 6% (n=3) of 
IUD clients and 1% (n=8) of implant clients said they 
had some regret in having chosen their particular 
family planning method. These clients were asked no 
additional questions related to regret.  
Overall satisfaction with the outreach service was the 
same for groups of women accessing tubal ligation, 
IUD and implant services, with 95% of clients 
indicating that the quality of service they received was 
either as expected or better than expected. 
Two percent (n=6) of IUD clients were dissatisfied with 
the service due to the attitude of the provider. These 
clients (n=6) also indicated additional reasons for 
Findings
Data Source: Client exit interview
FIGURE 4: Client history
Breast feeding information
Obstetrics history
Antibiotics use
Current / past episodes of breast
Episodes of migraines / headaches
Heart diseases
Diabetes
Hypertension
0%  20%  40%  60%  80%  100%
78%
53%
94%
74%
43%
48%
66%
83%
t  r : li t Provid r Observation
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TABLE 7: Provider observation on quality of care
Asked about Medical History Percentage of clients asked (%) (N= 665)
Smoking 36%
Diabetes 66%
Hypertension 83%
Heart disease 48%
Headache (migraine) 43%
Breast cancer (past and current) 74%
On antibiotics 53%
Obstetrics history 94%
Breastfeeding 78%
Asked about reproductive history Percentage of clients asked (%) (N= 665)
Number of children alive 93%
Desired number of children 51%
Age of youngest child 72%
Timing of next birth 49%
Date of last menses 90%
Intercourse since last menses 43%
Signs and symptoms of pregnancy (tender breasts or nausea) 25%
Previous use of family planning 89%
Asked about STI and HIV risk Percentage of clients asked (%) (N= 665)
Unprotected sex (vaginal, anal, oral) 24%
More than one concurrent partner 3%
Partner has more than one concurrent partner 2%
Injects Drugs 2%
Safer sex counselling carried out by provider Percentage of clients asked (%) (N= 665)
HIV Counselling 61%
Individual situation taken into account during safer sex counselling 41%
All relevant options for safer sex discussed 38%
Abstinence 18%
Offered an HIV test 45%
Mutual monogamy 16%
Condom use 84%
Findings
Data Source: Client Provider Observation
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TABLE 8: SRH services that were offered to clients seeking family planning services at the PSZ outreach sites 
3  It is PSZ practice to provide a reasonable amount of reimbursement for clients who accept permanent methods to support their transport home. 
FIGURE 5: Recommending PSZ family planning services 
Family planning service 
met your needs
Will use this service site again
Recommend PSZ family planning 
service to a friend
Recommend PSZ family planning 
service to a family member
Recommend PSZ family planning 
service to a stranger
0%  20%  40%  60%  80%  100%
Data Source: Client Exit Interview
100%
100%
68%
57%
21%
SRH Services (N=655) Responses % (n)
HIV and AIDS test counselling 61% (n= 399)
Counselling on dual protection 100% (n= 655)
Breast Cancer & other gynecological issues 62% (n= 406)
Pregnancy testing 27% (n= 176)
Gender-based violence 12% (n= 78)
STI services (information, testing and treatment) 58% (n=379)
Data Source: Client Provider Observation
being unsatisfied with the service including the lack of 
transport to the site (n=4), no provision of blankets 
during the procedure (n=3) and insufficient financial 
compensation for travel to and from the site of service 
provision (n=3).3   
 
Level of integration of HIV services into 
contraceptive or SRH services
Each client was observed on whether they received 
HIV and AIDS counselling, counselling on dual 
protection, obstetrics history and breast cancer, 
pregnancy testing, gender-based violence and STI 
services (information, testing and treatment). 100% of 
clients were provided counselling on dual protection, 
with 61% receiving HIV and AIDS test counselling. 
Table 8 provides with an indication of SRH related 
services that were observed being provided to clients.
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4.5 Adverse events  
Information on adverse events (including side effects 
and complications) was collected on the Day 15 follow 
up visit using the client follow up interview tool (see 
Appendix). Interviewers asked about the existence and 
severity of symptoms from the day of the procedure up 
to and including Day 15 follow up. 91% (n=555) of 
clients returned on Day 15 and completed the follow up 
questionnaire. 
Clients were asked to indicate the symptoms that they 
experienced on day of the procedure; post procedure 
(between the day of the procedure and the 15 day 
follow up visit) and whether the symptoms were still 
present at the 15 day follow up visit. It should be noted, 
that client reports were not verified by clinical or 
client-provider observation in relation to the medical 
intervention required. For this study, based on the 
clients’ self-reported symptoms and level of 
intervention, adverse events were categorised as “very 
mild”, “mild”, “moderate” or” severe” per Table 5 (see 
page 15).
Occurrence and frequency of side effects
65% (n=386) of all clients reported experiencing 
symptoms at some point between the day of the 
procedure and Day 15. Most clients reported 
experiencing side effects on the day of the procedure 
and indicated they were expected. 32% (n=180) of 
clients indicated that they experienced a side effect up 
to Day 15. Among implant acceptors, 32% experienced 
some side effect on the day of the procedure and 21% 
stated they experienced side effects between the day 
of the procedure and the 15 day visit. 3% (n=16) of 
these clients stated they still experienced the side 
effect, however, only one client had to have their family 
planning method removed. Among tubal ligation 
acceptors (n=7), one reported still experiencing the 
side effect at Day 15.
Adverse events on day of procedure
The summary of adverse events reported on the day of 
the procedure is detailed in Table 9. Amongst the 
implant clients 32% (n=168) reported experiencing 
pain. 17% (n=89) were categorised as experiencing 
“moderate” pain, requiring something stronger than 
paracetamol. 1% (n=6) self-reported taking pain relief 
medication for symptoms, which was categorised as 
“mild” side effects and 14% (n=73) reported slight pain 
(categorised as “very mild”) which they had 
experienced only during the insertion of the Implant.
All tubal ligation clients experienced some amount of 
pain on the day of the procedure. 71% of tubal ligation 
clients experienced pain that was either “very mild” or 
“mild” at the time of the procedure. 14% experienced 
moderate pain and no clients experienced “severe” 
pain.
IUD clients reported that some of them (2%, n=7) 
experienced “severe” pain on the day of the procedure. 
Bleeding that was categorised as “very mild” was 
reported for 94% of implant acceptors and 27% of IUD 
acceptors (including a combination of bleeding at 
insertion site and vaginal bleeding). Of the IUD clients 
that reported bleeding, 1% (n=3) reported that they 
experienced bleeding which lasted up to three days 
from the day of the procedure.
Adverse events on Day 15 post procedure
All tubal ligation clients returned for the 15 day follow 
up visit. 57% (n= 4) and 29% (n=2) of clients reported 
experiencing pain and bleeding respectively. One 
client was recorded as experiencing mild haematoma 
or bruising but no treatment was required. One other 
client experienced bruising that required wound 
revision and the release of build-up of blood. 
At Day 15, as compared to tubal ligation acceptors, a 
higher proportion of IUD clients reported side effects, 
such as pain and bleeding. 73% (n=35) of IUD clients 
reported experiencing some type of pain.  62% of 
these clients were categorised as reporting either 
“very mild” or “mild” pain. 10% of these clients were 
categorised as experiencing “moderate” pain. Three 
clients reported still “experiencing severe cramping 
pains”, and three clients reported “abdominal pain 
during intercourse since IUD insertion”. Two clients 
reported experiencing “slight temperature and fever, 
abdominal pain, unusual discharge developed within 
the 15 days following IUD insertion”, one client 
reported experiencing a “constant high temperature 
(required antibiotics and improved within seven days)” 
and another client reported experiencing “no 
improvement after seven days of antibiotic treatment”.  
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TABLE 9: Types of adverse events experienced on the day of procedure
Signs and symptoms reported experienced 
on day of procedure
Implants 
(Jadelle) 
(N=532)
IUD 
(N=48)
Tubal ligation 
(N=7)
Pain Very Mild 14% 2% 29%
 Mild 1% 1% 43%
 Moderate 17% - 14% 
 Severe 1% -
Total “Pain” side effect 168 17 7
Bleeding  Very Mild 94% 27% 14% 
 Mild 6% 2% 0
 Moderate 0 0 0
 Severe 0 1% 0
Total “bleeding” side effect 206 24 1
Data source: 15 day follow up interview
TABLE 10: Types of adverse events experienced at 15 days post procedure 
Implants 
(n=532)
IUD 
(N=48)
TL (n=7)
Pain Very Mild 15% (n=79) 27% (n=13) 29% (n=2)
 Mild 5% (n=25) 35% (n=17) 14% (n=1)
 Moderate 1% (n=4) 10% (n=5) 14% (n=1)
 Severe 0% (n=1) - -
Total “pain” side effects reported 109 35 4
Bleeding  Very Mild 2% (n=8) 35% (n=17) 14% (n=1)
 Mild - 8% (n=4) -
 Moderate - 2% (n=1) -
 Severe - - 15% (n=1)
Total  “bleeding” side effects reported 8 22 2
Data source: 15 day follow up interview
l i  at insertion 
site for “Implants 
and Tubal Ligation”&  
“Vaginal bleeding” 
for IUD
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Of the 532 implant clients who participated in the 
follow-up interview on Day 15, 64% (338) reported 
some level of pain at some point in time. There were 
no reports of bleeding at Day 15. 15% (n=79) of clients 
reported pain that continued for more than one day 
post-procedure. This side effect was categorised as a 
“very mild” side effect. 
Information was collected from implant acceptors 
related to menstrual bleeding and breast tenderness 
(see Table 12).  3% (n=17) of clients experienced 
prolonged bleeding lasting longer than eight days. 
4.6 Follow up care and health seeking 
behaviour by Day 15  
All clients who attended the follow up visit and 
reported experiencing an adverse event were asked 
whether they sought care irrespective of the level of 
severity. 96% of clients reported that no care or 
additional treatment was required for their side effect. 
Figure 6 shows the reasons clients cited for not 
seeking care. Most clients indicated that they did not 
get time off from their household chores to seek care. 
Additionally, lack of concern from their partners or 
family members and thinking that the side effect 
symptoms will subside over time, were cited as well. 
Two percent (n=8) of clients reported seeking care at a 
health facility however only 63% (n=5) reported that 
TABLE 11: Implant clients self-report on menstrual bleeding and breast tenderness
Menstrual bleeding
Lighter, fewer days, irregular and infrequent 8% (n=45)
Prolonged bleeding that lasts longer than 8 days 3% (n=17)
Heavier bleeding that is 2 times as usual 1% (n=6)
Heavy or prolonged bleeding continuing 2% (n=12)
Change in breast since Implants
New lump in breast since Implants inserted 0.17% (n=1)
Breast tenderness & soreness 0.3% (2)
Data source: 15 day follow up interview
they were satisfied with the help that they had received 
and the remainder of the clients who were not 
satisfied, cited that they still experienced the side 
effect at the Day 15 follow up visit.   
Another 2% (n=8) reported that they had contacted 
PSZ to discuss care and treatment. All these clients 
reported that they were advised to return to the health 
care facility and see a facility provider, should their 
symptoms continue, however only 50% (n=4) of these 
clients returned to the facility and were seen by a 
facility provider prior to the Day 15 follow up. These 
clients reported that the facility provider dispensed 
“pain medication” and that they received counselling 
and were asked to return at the Day 15 follow up and 
report to the PSZ provider any side effects that they 
were still experiencing. 
The 50% of clients who did not return to the facility 
indicated that the facility was too far and that they 
would wait for the Day 15 follow up visit to return to the 
clinic. 
A review of the side effects of the 2% of clients that 
contacted PSZ indicated that the “pain” & “bleeding 
around the insertion site” was reported, however these 
symptoms had subsided and these symptoms were no 
longer experienced at the 15 day follow up visit.  
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FIGURE 6: Reasons for clients not seeking health care when experiencing adverse event
Client; it would subside
PSZ provider: it would subside
Lack of concern by family
Did not get time off
No one to go with
Costs Money
Called the PSZ help line
0%  20%  40%  60%  80%  100%
Data Source: 15 Day Follow-Up tool 
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11%
96%
99%
33%
2%
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Resumption of normal activities and work
7% (n=3) of the IUD clients, and 2% (n=8) of implant 
clients reported that they were still unable to work as 
normal on Day 15 post-procedure.  Of the clients who 
reported being unable to work, two IUD clients and 
four of the implant clients attributed this to pain, one of 
the IUD clients and three of the implant clients said it 
was due to insertion site bleeding, and 7% (n=3) of 
IUD clients and 0.4% (n=2) of implant clients reported 
“back ache” as the reason for non-resumption of 
normal activities and work.  
4.7 Myths and misconceptions 
All clients were asked whether they agreed with 
common misconceptions of family planning at the 
client exit interview. It was interesting to note that a 
large percentage of clients (52%) thought that 
“condoms often break during sex”. Some commonly 
reported beliefs included: women who have never had 
a baby cannot use an IUD or DMPA and IUDs cause 
discomfort to the partner during sex. Some clients felt 
that hormonal contraceptives could cause cancer and 
as many as 29% of clients said pills can make a 
woman sterile. Detailed findings on myths and 
misconceptions are shown in Table 12. 
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TABLE 12: Myths and misconceptions as reported by the client
Contraception Misconception Percentage 
(N=665)
IUD 
An IUD can travel from the woman’s uterus to other parts of 
her body, such as her heart or brain
13% (n=85)
An IUD can prevent a woman from having babies after it is 
removed
15% (n=96)
An IUD can prevent a woman from having babies after it is 
removed
20% (n= 27)
A woman should have a “rest period” after using an IUD for 
several years
9% (n= 55)
An IUD will cause discomfort to the woman’s partner during 
sex
26% (n= 167)
Hormonal (Injectable) Women without children cannot use depot 
medroxyprogesterone (DMPA)
23% (n= 146 )
DMPA causes cancer 19% (n=121)
DMPA causes abortion 12% (n= 76)
Hormonal (“Pill”) “Pills” cause cancer 16% (n= 84)
A woman should take a break from “pills” after some time 8% (n=45)
“Pills” will cause deformed babies 18% (n=108)
Pills” can make a woman sterile 29% (n= 168)
A woman should not take “pills” if she has not had a baby 24% (n=154)
“Pills” can make a woman weak 16% (n=85)
Data Source: Client Exit questionnaire
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5.1 Discussion 
 
PSZ mobile outreach services are an ideal platform to 
provide clients with integrated services especially 
around HIV and STIs. Clients are offered a full method 
mix of contraception during PSZ visits, but the uptake 
of IUD, tubal ligation and Implants tends to be high as 
other short acting methods of contraception are 
routinely available to women through the MOHCC 
service delivery. The study has shown that levels of 
satisfaction with PSZ services are high and there are 
low levels of severe adverse events. The analysis 
indicated that clients received accurate family planning 
information and that they were happy with the quality 
and quantity of information pertaining to their choice of 
family planning including how to manage common side 
effects.  
 
Quality of care
The analysis revealed that in the majority of cases 
(83%), providers encouraged clients to ask questions 
to establish their understanding of family planning. This 
interaction and discourse may have contributed to 
clients indicating that they would return to the site for 
family planning services as a strong rapport was often 
built. All providers were observed taking the client’s 
medical history and, the data revealed that some 
information – such as obstetric information – was taken 
for a large percentage of clients. Although all clients 
(100%) stated that they were happy and satisfied with 
the family planning service, not all clients indicated that 
they would refer a friend or a family member to the 
family planning site. 21% of clients indicated that they 
would refer the service to a stranger. It is likely that 
clients indicated low referral to family, friends and 
strangers due to family planning being considered a 
personal issue that should not be discussed with 
others. With regard to integration of other SRH 
services, 61% of clients were asked about risk factors 
for HIV, offered or referred for an HIV test.  Given the 
high prevalence of HIV in this sexually active client 
population accessing contraceptive services, there is 
room for strengthening this aspect of service provision. 
 
Incidence of side effects 
The analysis revealed that clients were informed and 
knowledgeable about potential side effects and what 
action to take should they experience a side effect. 
5. Discussion and 
recommendations
Most clients (94%) received information on what to do 
if they experienced a side effect, and the information 
was relevant to their contraceptive method. Client’s 
health-seeking behaviour was documented by what 
they did before arriving at the clinic for their Day 15 
visit. The data showed that clients were able to seek 
assistance when they experienced a side effect as 
they knew how to access the facility and 2% of clients 
called the PSZ helpline. 65% (n=386) of clients 
reported experiencing symptoms at some point 
between the day of the procedure and Day 15. Most 
clients reported experiencing side effects on the day of 
the procedure and indicated they were expected. 32% 
(n=180) of clients indicated that they experienced a 
side effect up to Day 15.
  
Study limitations 
 
This study provided an overall indication of the quality 
of family planning services (objective 1) and the timing, 
frequency and type of side effect/s (objective 2) 
experienced. Certain limitations were encountered. 
Clients who returned to the facility prior to the 15-day 
follow-up visit were unable to provide complete 
information about their consultation/visit with the 
facility providers. This included the type of treatment 
received and the purpose of the drugs dispensed for 
the side effect that they were experiencing. The study 
relied on self-reporting by the client. The study did not 
track the follow-up care of the 1% of clients who had 
their family planning method removed due to side 
effects experienced. The study also did not explore 
why, despite being satisfied with the service and willing 
to use it again, only 68% of clients indicated that they 
would refer the family planning service to a friend, 57% 
would tell a family member about the family planning 
services and 21% would tell a stranger about the 
service. 
The follow up period of 15 days was short, and 
therefore the study does not provide a good reflection 
of longer term side effects, such as changes in 
menstrual bleeding which may emerge over time, or of 
discontinuation behaviours over a longer term.  
Due to the small sample size (related to the duration 
and available resources for the study) it was not 
possible to further analyse the characteristics of the 
clients who experienced side effects from IUDs and 
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ultimately discontinued the method. Due to the follow 
up processes in the study design, it was difficult to 
further determine the exact cause of the (small) 
number of side effects.  
While clients were asked about receiving their 
preferred family planning method, their reasons for 
seeking family planning services and rationale for the 
selected method were not explored in this study.  
Partner, spouse or family member involvement was not 
addressed in this study as it is known that women are 
not only influenced or informed by their choice of 
method by providers but by close family members as 
well.
As with other prospective studies measuring post 
procedure outcomes, without strict medical verification 
and control, it is difficult to differentiate side effects as 
a result of the procedure from symptoms relating to the 
clients’ conditions or living environment that may 
exacerbate the client’s experience of side effects. 
5.2 Conclusion  
 
The study aimed to evaluate the quality of care 
provided by PSZ mobile outreach model in Zimbabwe. 
The findings reveal that PSZ provides a critical health 
service to women, especially those between the age of 
15 years and 29 years who live in rural areas. PSZ 
mobile teams expand access and choice of family 
planning methods to women who otherwise would not 
receive these services. Overall, clients indicated that 
they were satisfied with the quality of services they 
received from PSZ. Clients were well informed on how 
to manage side effects and their health-seeking 
behaviour attested to this. In addition, health-seeking 
behaviour such as seeking care at the facility, calling 
the PSZ helpline and returning at the 15 day follow-up 
visit (which was facilitated by the study and does not 
happen during normal operations) is an indication that 
women are aware of how to seek care and what to do 
in the event of a side effect. Determining access to 
care was also assessed and the data revealed that the 
women received the service they needed when they 
arrived at the facility or the mobile site. At the Day 15 
follow up, one woman experienced a severe side effect 
(an implant user reporting pain) and no complications 
were reported amongst those clients interviewed. 
These rates are similar to other published studies of 
the experiences of mobile outreach clients [16, 17]. 
This study also highlighted areas of service that 
require strengthening and opportunities to improve 
integrated SRH service delivery such as testing and 
re-testing for HIV, partner involvement and STI 
treatment and care and the potential to provide more 
information on other sexual and reproductive health 
issues. 
5.3  Recommendations 
 
It is recommended that PSZ consider the following to 
strengthen services:
•  Clients are at significant risk of HIV and there is an 
opportunity to integrate more information and HIV 
related services into the routine family planning 
consultation. 
•  A significant proportion of clients continue to have 
misconceptions and incorrect information about 
various contraceptive methods. PSZ health care 
providers should continue to focus on correcting 
myths and misconceptions routinely in group or 
individual counselling as part of their family 
planning community outreach activities. 
•  Although in some instances providers are using the 
family planning consultation to integrate information 
on other sexual and reproductive health issues, 
there is room for strengthening this component and 
reducing missed opportunities to provide 
information.
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